This transaction
Acquisition of shares in this transactionThe voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Wholesale of beauty and healthcare products; investment business
The impact on results of operations and financial condition for the fiscal year ending March 2027 is currently under review.
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares in this transaction |
| Counterparty name | UNIVA Group Investments Limited(Cayman) |
| Name of the Subject Company | UNIVA Marketing Limited(Cayman) |
| Business Description of the Subject Company | Wholesale of beauty and healthcare products; investment business |
| Location of the Subject Company | Cayman Islands |
| Capital Stock of the Subject Company | NTD 5,200,000 (¥25,896,000) |
| Date of Establishment of the Subject Company | 29 June 2018 |
| Acquisition price | ¥895,000,000 (receivable from UGI for the consideration for the transfer of UMKY shares) |
| Type of Consideration | Share consideration through a third-party allotment capital increase, with the receivable for the acquisition consideration contributed in kind instead of cash |
| Number of shares acquired | 265,200 shares (number of voting rights: 265,200) |
| Voting rights ownership percentage | After 51% (before not disclosed) |
| Funding arrangements | Contribution in kind of the receivable from UGI for the consideration for the acquisition of UMKY shares |
| Impact on Business Performance | The impact on results of operations and financial condition for the fiscal year ending March 2027 is currently under review. |
| Date of board resolution | 13 March 2026 |
| Execution Date / Effective Date | 1 April 2026 (completed) |
| Management structure after acquisition | The representative of UMKY is Director Inaba Shuji (稲葉秀二). UMKY is expected to become a consolidated subsidiary of the Company. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose and rationale for this transaction are not explained in this document.